Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.80% | -51.17% | -21.18% | 24.12% | 12.92% |
| Total Depreciation and Amortization | 12.69% | -28.74% | -22.77% | -22.63% | -28.35% |
| Total Amortization of Deferred Charges | -- | 7.15% | -- | -- | -- |
| Total Other Non-Cash Items | -36.76% | -187.62% | -86.92% | -317.76% | 1,180.56% |
| Change in Net Operating Assets | -80.67% | 99.59% | 491.43% | -341.31% | -124.37% |
| Cash from Operations | -48.58% | 123.76% | 2.45% | -77.08% | -69.42% |
| Capital Expenditure | 29.75% | 1.23% | -4.08% | 7.71% | 7.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -20,572.22% | -100.00% | 69.23% | 31.62% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.38% | 433.56% | 84.63% | -188.03% | 26.83% |
| Cash from Investing | 104.46% | -59.18% | 41.63% | -21.73% | 27.45% |
| Total Debt Issued | -46.48% | 1,385.84% | -- | 511.69% | -46.12% |
| Total Debt Repaid | -132.94% | -390.78% | -188.32% | 171.81% | 75.62% |
| Issuance of Common Stock | -76.29% | -60.00% | 54.84% | 57.89% | 125.58% |
| Repurchase of Common Stock | -50.60% | -95.47% | 86.25% | 28.44% | 7.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.85% | -7.80% | -8.62% | -8.00% | -7.98% |
| Other Financing Activities | -450.00% | -450.00% | -- | 33.33% | 100.00% |
| Cash from Financing | -6,065.63% | 457.36% | 7.95% | 146.71% | 106.03% |
| Foreign Exchange rate Adjustments | -- | -900.00% | 275.00% | -600.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.67% | 109.61% | 47.52% | 279.47% | -110.89% |